izpis_h1_title_alt

Effect of electrochemotherapy on myogenesis of mouse C2C12 cells in vitro
ID Kranjc Brezar, Simona (Author), ID Medved, Ajda (Author), ID Matkovič, Urška (Author), ID Serša, Gregor (Author), ID Markelc, Boštjan (Author), ID Božič, Tim (Author), ID Jurdana, Mihaela (Author), ID Čemažar, Maja (Author)

.pdfPDF - Presentation file, Download (6,17 MB)
MD5: 2BB1226260E890A5B3B5C3BE5F709E4B
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S156753942300124X This link opens in a new window

Abstract
Electrochemotherapy (ECT) is a local ablative therapy for the treatment of different skin and subcutaneous tumors and certain tumors in internal organs. Skeletal muscle represents a major tumor-surrounding tissue, exposed to side effects of ECT. At the cellular level, side-effects of ECT on skeletal muscle and underlying mechanisms have not been examined yet. Thus, we aimed to determine the effect of ECT in the mouse muscle cell line C2C12 during in vitro myogenesis. We evaluated the electroporation efficiency and viability of C2C12 myotubes at increasing voltages (200–1300 V/cm) using propidium iodide (PI). Permeabilization of PI into the cells was voltage-dependent accounting up to 97 % efficiency at the highest voltage. High cell viability and myotube integrity were maintained until 4 days after electroporation. ECT with the cytostatic drugs bleomycin and cisplatin decreased the viability of C2C12 myoblasts and myotubes in a dose-dependent manner. However, myoblasts were more sensitive to ECT than myotubes. Increased secretion of IL-6, observed 3 days after ECT, confirming its effects on early myogenesis. Only minor effects of ECT were observed in treated myotubes. These results contribute to the safety profile of ECT in tumor treatment.

Language:English
Keywords:electroporation, electrochemotherapy, myogenesis, bleomycin, cisplatin, skeletal muscle
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:7 str.
Numbering:Vol. 153, art. 108487
PID:20.500.12556/RUL-152845 This link opens in a new window
UDC:616-083
ISSN on article:1567-5394
DOI:10.1016/j.bioelechem.2023.108487 This link opens in a new window
COBISS.SI-ID:156727811 This link opens in a new window
Publication date in RUL:08.12.2023
Views:217
Downloads:26
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Bioelectrochemistry
Publisher:Elsevier
ISSN:1567-5394
COBISS.SI-ID:2502484 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:elektroporacija, elektrokemoterapija, miogeneza

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0003
Name:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back